Antiretroviral Regimens
(2000-2009)

Number of persons on each regimen 

Proportion of persons on each regimen (%)

Number of persons  with toxicity

Proportion of persons with toxicity (%)

Toxicity rate of each regimen (%)

Zidovudine/Lamivudine/Nevirapine

2025

55.6

185

51.8

  9.1

Stavudine/Lamivudine/Nevirapine

1145

31.4

  59

16.5

  5.2

Truvada+ Nevirapine

170

  4.7

  37

10.4

 21.8

*Zidovudine + truvada+ ritonavir
boosted lopinavir

160

  4.4

  31

  8.7

 19.4

Zidovudine/Lamivudine+ Efavirenz

  78

   2.1

  23

  6.4

 29.5

Truvada/Efavirenz

  58

   1.6

  20

  5.6

 34.5

Stavudine+Lamivudine+Efavirenz

     5

   0.1

    2

  0.6

 40.0

Total 

3641

100.0

357

100

 9.8


*Second line regimen
Table 2: The pattern of antiretroviral regimens use and proportional toxicities.
Goto home»